The absence of widespread testing continues to be a major roadblock when it comes to curbing the spread of the coronavirus in the U.S. One company, ConcertoHealth, is helping to close the care gap with its home-based COVID-19 testing and treatment program.
Since the start of the COVID-19 emergency, many people in the U.S. have faced barriers in getting tested for the virus. That, in turn, has made it difficult to determine the exact number of cases and take action.
Seniors who are especially vulnerable to the virus have even less access to testing, Dr. Chris Dodd, chief clinical officer of ConcertoHealth, told Home Health Care News.
“These patients can’t get to clinics or to these community-based testing sites with ease, or at all,” he said. “We knew we had to get to them. At the time, even local public health departments didn’t have the testing resources that they needed to get to these patients.”Full Article (external)
ConcertoHealth Inc. is the leading risk-bearing provider of field-based complex care for persistently high-cost and rising-risk populations. The company’s multidisciplinary care teams meet patients where they are, with the care they need, whether in the home or hospital. The ConcertoHealth care model improves overall health quality and outcomes with a track record of reducing hospital admits by 47%, readmits by 40% and ER visits by 16% for the most frail and vulnerable populations in America, benefiting patients, payers and provider networks alike.